Antares Pharma Inc (ATRS.OQ) Quote| Reuters.com
Edition:
United States

Antares Pharma Inc (ATRS.OQ)

ATRS.OQ on NASDAQ Stock Exchange Capital Market

1.11USD
4:00pm EDT
Change (% chg)

$0.06 (+5.71%)
Prev Close
$1.05
Open
$1.05
Day's High
$1.13
Day's Low
$1.05
Volume
171,368
Avg. Vol
309,167
52-wk High
$2.35
52-wk Low
$0.67

ATRS.OQ

Chart for ATRS.OQ

About

Antares Pharma, Inc. (Antares) is a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. The Company develops and manufactures pressure-assisted injector devices, with and without needles, which allow patients to self-inject drugs.... (more)

Overall

Beta: 0.66
Market Cap(Mil.): $162.67
Shares Outstanding(Mil.): 154.93
Dividend: --
Yield (%): --

Financials

  ATRS.OQ Industry Sector
P/E (TTM): -- 47.30 34.67
EPS (TTM): -0.14 -- --
ROI: -43.85 11.65 14.11
ROE: -45.30 13.66 15.33

BRIEF-Teva and Antares Pharma announce launch of Generic Imitrex in the U.S.

* Teva and Antares Pharma announce launch of Generic Imitrex in the United States Source text for Eikon: Further company coverage:

Jun 27 2016

BRIEF-Antares Pharma posts Q1 loss per share of $0.05

* Antares Pharma reports first quarter 2016 operating and financial results

May 09 2016

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : Stock Traders Daily
$20.00
Provider : New Constructs, LLC
$25.00
Provider : ValuEngine, Inc.
$25.00
Provider : S&P Capital IQ Quantitative Report
$115.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.